NDAINTRAVENOUSINJECTABLE
Approved
Feb 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
INFUVITE PEDIATRIC (multiple vitamins injection) by Novartis. Approved for vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition (). First approved in 2001.
Drug data last refreshed 2d ago
Mechanism of Action
Pharmacologic Class:
Vitamin C
Company
Worked on INFUVITE PEDIATRIC at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.